Cargando…
Protective effects of muscone on traumatic spinal cord injury in rats
BACKGROUND: Traumatic spinal cord injury (SCI) is a major clinical concern, and it is a life-changing neurological condition with substantial socioeconomic implications. Muscone has been widely used in traditional Chinese medicinal formulations for its anti-inflammatory activity. However, its protec...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279775/ https://www.ncbi.nlm.nih.gov/pubmed/35845509 http://dx.doi.org/10.21037/atm-22-2672 |
_version_ | 1784746475788435456 |
---|---|
author | Yu, Chao Gui, Fei Huang, Qian Luo, Yuanmeng Zeng, Zili Li, Ruifu Guo, Liang |
author_facet | Yu, Chao Gui, Fei Huang, Qian Luo, Yuanmeng Zeng, Zili Li, Ruifu Guo, Liang |
author_sort | Yu, Chao |
collection | PubMed |
description | BACKGROUND: Traumatic spinal cord injury (SCI) is a major clinical concern, and it is a life-changing neurological condition with substantial socioeconomic implications. Muscone has been widely used in traditional Chinese medicinal formulations for its anti-inflammatory activity. However, its protective effects on traumatic SCI have not been explored. This study investigated whether muscone plays a protective role in SCI and compared its effects with those of methylprednisolone sodium succinate (MPSS). METHODS: Rats were divided into five groups: normal saline (NS; n=24), methylprednisolone (MP; w=24), and muscone 1 (MO1), muscone 2 (MO2), and muscone 3 (MO3) (n=24 in each group, collectively called the MOx groups). The SCI rat model was established by the modified Allen’s method. The rats were administered muscone (MO1: 2.5 mg/kg, MO2: 5 mg/kg, and MO3: 10 mg/kg) or MP (30 mg/kg), or an equivalent volume of saline. The rats were kept under observation for 4 weeks. Malondialdehyde (MDA), superoxide dismutase (SOD), interleukin-6 (IL-6), interleukin-1β (IL-1β), and tumor necrosis factor-alpha (TNF-α) levels were detected using enzyme-linked immunosorbent assay (ELISA). The expression of glial fibrillary acidic protein (GFAP), B-cell lymphoma-2 (BCL-2), and caspase3 was detected by western blot analysis. Hematoxylin-eosin (HE), Nissl, and immunocytochemistry (ICC) staining was performed for pathological observation. Basso-Beattie-Bresnahan motor function scores were evaluated for assessment of neural functions after acute SCI. RESULTS: Muscone inhibited immune-inflammatory reactions, neuronal necrosis, and apoptosis. The lower limb function recovery was better in the MOx groups compared with NS and MP groups according to Basso-Beattie-Bresnahan scores. The changes were remarkable in the MO2 group compared with the other groups. CONCLUSIONS: Muscone alleviates secondary injury after SCI by reducing immune-inflammatory reactions, neuronal necrosis, and apoptosis. |
format | Online Article Text |
id | pubmed-9279775 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-92797752022-07-15 Protective effects of muscone on traumatic spinal cord injury in rats Yu, Chao Gui, Fei Huang, Qian Luo, Yuanmeng Zeng, Zili Li, Ruifu Guo, Liang Ann Transl Med Original Article BACKGROUND: Traumatic spinal cord injury (SCI) is a major clinical concern, and it is a life-changing neurological condition with substantial socioeconomic implications. Muscone has been widely used in traditional Chinese medicinal formulations for its anti-inflammatory activity. However, its protective effects on traumatic SCI have not been explored. This study investigated whether muscone plays a protective role in SCI and compared its effects with those of methylprednisolone sodium succinate (MPSS). METHODS: Rats were divided into five groups: normal saline (NS; n=24), methylprednisolone (MP; w=24), and muscone 1 (MO1), muscone 2 (MO2), and muscone 3 (MO3) (n=24 in each group, collectively called the MOx groups). The SCI rat model was established by the modified Allen’s method. The rats were administered muscone (MO1: 2.5 mg/kg, MO2: 5 mg/kg, and MO3: 10 mg/kg) or MP (30 mg/kg), or an equivalent volume of saline. The rats were kept under observation for 4 weeks. Malondialdehyde (MDA), superoxide dismutase (SOD), interleukin-6 (IL-6), interleukin-1β (IL-1β), and tumor necrosis factor-alpha (TNF-α) levels were detected using enzyme-linked immunosorbent assay (ELISA). The expression of glial fibrillary acidic protein (GFAP), B-cell lymphoma-2 (BCL-2), and caspase3 was detected by western blot analysis. Hematoxylin-eosin (HE), Nissl, and immunocytochemistry (ICC) staining was performed for pathological observation. Basso-Beattie-Bresnahan motor function scores were evaluated for assessment of neural functions after acute SCI. RESULTS: Muscone inhibited immune-inflammatory reactions, neuronal necrosis, and apoptosis. The lower limb function recovery was better in the MOx groups compared with NS and MP groups according to Basso-Beattie-Bresnahan scores. The changes were remarkable in the MO2 group compared with the other groups. CONCLUSIONS: Muscone alleviates secondary injury after SCI by reducing immune-inflammatory reactions, neuronal necrosis, and apoptosis. AME Publishing Company 2022-06 /pmc/articles/PMC9279775/ /pubmed/35845509 http://dx.doi.org/10.21037/atm-22-2672 Text en 2022 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Original Article Yu, Chao Gui, Fei Huang, Qian Luo, Yuanmeng Zeng, Zili Li, Ruifu Guo, Liang Protective effects of muscone on traumatic spinal cord injury in rats |
title | Protective effects of muscone on traumatic spinal cord injury in rats |
title_full | Protective effects of muscone on traumatic spinal cord injury in rats |
title_fullStr | Protective effects of muscone on traumatic spinal cord injury in rats |
title_full_unstemmed | Protective effects of muscone on traumatic spinal cord injury in rats |
title_short | Protective effects of muscone on traumatic spinal cord injury in rats |
title_sort | protective effects of muscone on traumatic spinal cord injury in rats |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279775/ https://www.ncbi.nlm.nih.gov/pubmed/35845509 http://dx.doi.org/10.21037/atm-22-2672 |
work_keys_str_mv | AT yuchao protectiveeffectsofmusconeontraumaticspinalcordinjuryinrats AT guifei protectiveeffectsofmusconeontraumaticspinalcordinjuryinrats AT huangqian protectiveeffectsofmusconeontraumaticspinalcordinjuryinrats AT luoyuanmeng protectiveeffectsofmusconeontraumaticspinalcordinjuryinrats AT zengzili protectiveeffectsofmusconeontraumaticspinalcordinjuryinrats AT liruifu protectiveeffectsofmusconeontraumaticspinalcordinjuryinrats AT guoliang protectiveeffectsofmusconeontraumaticspinalcordinjuryinrats |